Introduction {#S0005}
============

The majority of respiratory system cancers and pulmonary vascular diseases are attributable to cigarette smoking \[[@CIT0001], [@CIT0002]\]. Smoking is also linked to cardiovascular diseases \[[@CIT0003]\], stroke \[[@CIT0004]\] and fertility disorders \[[@CIT0005]\]. Moreover, an increased risk of mortality from cardiovascular diseases and cancer has been associated with cigarette smoking and exposure to cigarette smoke \[[@CIT0006]--[@CIT0008]). Prior studies examining the relationship between all-cause mortality and cigarette smoking have identified gender differences \[[@CIT0009]\]; and alteration of cholesterol metabolism \[[@CIT0010], [@CIT0011]\] as significant contributing factors to the increased risk of death among active smokers.

Coenzyme Q~10~ (CoQ~10~), a lipid-soluble compound synthesized as part of the cholesterol pathway, is an essential cofactor in the mitochondrial respiratory chain, a potent antioxidant, and a potential biomarker for systemic oxidative stress \[[@CIT0012]--[@CIT0014]\]. Deficiencies in plasma CoQ~10~ have been reported in many patient groups, including certain cardiovascular \[[@CIT0015]\], neurological \[[@CIT0016]\], hematological \[[@CIT0017]\], neoplastic \[[@CIT0018]\], renal \[[@CIT0019]\], and metabolic diseases \[[@CIT0020]\]. Moreover, plasma CoQ~10~ concentration is an independent predictor of mortality in chronic heart failure \[[@CIT0021]\].

Previous studies have reported controversial effects of smoking on CoQ~10~. Smoking has been shown to be positively associated with plasma CoQ~10~ \[[@CIT0022], [@CIT0023]\], whereas other studies reported no association \[[@CIT0024], [@CIT0025]\] or a negative association with plasma CoQ~10~ levels \[[@CIT0026]\]. Numerous factors have been suggested to contribute to this controversy, including gender, the levels of plasma cholesterol and triglycerides \[[@CIT0025]\]. Therefore, we aimed to determine changes in CoQ~10~ concentration induced by cigarette smoking in healthy subjects and to investigate the possible association of plasma CoQ~10~ with gender and lipid profile.

Material and methods {#S0006}
====================

Reagents {#S20007}
--------

Methanol, ethanol and n-propanol were HPLC grades obtained from BDH (BDH Chemicals, Poole, Dorset, UK). Pure Coenzyme Q10 and benzoquinone were obtained from Sigma (St. Louis, MO, USA) and used as standard. Reagent kits for the analysis of blood glucose, total cholesterol, LDL-C, HDL-C and triglycerides were purchased from Biosystems (S.A., Costa Brava, Barcelona, Spain).

Subjects {#S20008}
--------

A total of 106 healthy volunteers (56 males, and 50 females), with an age range of 21-45 years and having no history of alcohol abuse or diseases such as diabetes mellitus or obesity, volunteered to participate in the research after their consent was obtained. Volunteers were excluded from the study if they were on antioxidant or lipid-lowering medication. The research has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association; and has been approved by the Ethics Committee of the university. Subjects were grouped according to their cigarette smoking status into non-smokers (*n* = 51) and smokers (*n* = 55) groups. Smoking status was assigned according to the following criteria: (1) at least 21 years old, (2) daily smokers, (3) at least a 5-year smoking history, (4) smoke at least 15 cigarettes per day. Anthropometric measurements such as height and weight were made following standard techniques.

Biochemical tests {#S20009}
-----------------

Blood samples were drawn at about 9.00 am after an overnight fast into heparinized Vacutainers (BD Diagnostics, Franklin Lakes, NJ, USA). Following centrifugation for 10 min at 4°C, plasma fraction was removed and stored at −80°C till analysis.

Fasting plasma glucose levels, total cholesterol (TC), triglycerides (TG), HDL-C, total protein and albumin were determined in all the subjects. Assays were performed with a Dade Behring Dimension RxL clinical chemistry system (Dade Behring; Germany) using its own kits. LDL-cholesterol (LDL-C) was calculated using the Friedewald\'s formula \[[@CIT0027]\]. The atherogenic ratio of TC/HDL-C as well as the atherogenic index of plasma (AIP), calculated as log (TG/HDL-C), with TG and HDL-C, were measured in molar concentrations \[[@CIT0028]\].

Total plasma coenzyme Q10 was measured by reverse-phase high performance liquid chromatography (HPLC) with ultraviolet detection using the method of Mosca *et al.* \[[@CIT0029]\] with a slight modification. The method is based on oxidation of CoQ~10~ in the sample by treating it with *para*-benzoquinone. Coenzyme Q~10~ was then quantitatively extracted into 1-propanol with a fast one-step extraction procedure, after centrifugation, samples were injected directly into the HPLC apparatus \[[@CIT0030]\]. Pre-oxidation of the sample ensures quantification of total CoQ~10~ by ultraviolet (UV) detection. The separation was performed using reversed-phase Supelcosil LC18 column (Supelco, Bellefonte, PA, USA). The mobile phase was represented by ethanol-methanol (65-35%). The flow rate was 1.5 ml/min and UV detection was carried out at 275 nm. This method achieves a linear detector response for peak area measurements over the concentration range of 0.05-3.47 µM with a CV of 1.6% for samples approaching normal values (1.02 µM). Supplementation of the samples with known amounts of CoQ~10~ yielded a quantitative recovery of 97.5-99%.

Statistical analysis {#S20010}
--------------------

Results were expressed as mean ± standard deviation. Statistical analysis was performed using an unpaired *t* test with *Welch\'s* correction. Correlation analysis was done using linear regression and Pearson\'s correlation coefficient. Statistical significance was defined by *p* \< 0.05. All statistical tests were two-tailed. Calculations were done using SPSS for Windows (release 13.0, 2004; SPSS Inc., Chicago, IL).

Results {#S0011}
=======

A total of 106 subjects (50 females and 56 males) met eligibility criteria and were grouped according to cigarette smoking habit into a non-smoking group (*n* = 51) and a currently smoking group (*n* = 55). No significant differences in age, sex or body mass index (BMI) were observed between studied groups ([Table I](#T0001){ref-type="table"}).

###### 

Age and body mass index (BMI) of female and male individuals for all groups

  Parameter                                          Gender              Non-smokers (*n* = 51)                   Smokers (*n* = 55)   Value of *p*[b](#TF0002){ref-type="table-fn"}
  -------------------------------------------------- ------------------- ---------------------------------------- -------------------- -----------------------------------------------
  Number (%)                                         Female (*n* = 50)   25 (49%)                                 25 (45%)             0.845[c](#TF0003){ref-type="table-fn"}
  Male (*n* = 56)                                    26 (51%)            30 (55%)                                                      
  Age \[years\][a](#TF0001){ref-type="table-fn"}     Female (*n* = 50)   36.3 ± 12.1                              34.6 ± 7.5           0.553
  Male (*n* = 56)                                    34.3 ± 12.7         35.1 ± 12.7                              0.815                
  Value of *p*                                       0.565               0.201[c](#TF0003){ref-type="table-fn"}                        
  BMI \[kg/m^2^\][a](#TF0001){ref-type="table-fn"}   Female (*n* = 50)   24.2 ± 3.0                               25.5 ± 3.3           0.153
  Male (*n=*56)                                      25.9± 2.0           27.0 ± 4.8                               0.258                
  Value of *p*                                       0.863               0.177[c](#TF0003){ref-type="table-fn"}                        

^a^Results are presented as mean ± SD,

^b^p values are calculated by unpaired t-test with Welch\'s correction,

^c^p value is calculated by Fisher\'s exact test (2-sided)

[Table II](#T0002){ref-type="table"} summarizes the main differences in the measured parameters between studied groups. There were no significant differences in plasma CoQ~10~ concentrations between male and female in the non-smoking group. In contrast, female smokers showed significantly (*p* \< 0.003) lower plasma CoQ~10~ levels than male smokers. In addition, plasma CoQ~10~ concentrations were significantly lower in male (*p* \< 0.006) and female (*p* \< 0.0001) smokers compared with their non-smoking counterparts. No significant differences were found between the studied groups regarding fasting blood glucose levels.

###### 

Plasma coenzyme Q10 (CoQ~10~) and biochemical parameters in studied groups

  Parameter[a](#TF0004){ref-type="table-fn"}   Gender              Non-smokers (*n* = 51)   Smokers (*n* = 55)   Value of *p*[b](#TF0005){ref-type="table-fn"}
  -------------------------------------------- ------------------- ------------------------ -------------------- -----------------------------------------------
  CoQ~10~ \[µmol/l\])                          Female (*n* = 50)   1.32 ± 0.30              0.44 ± 0.20          0.0001
  Male (*n* = 56)                              1.50 ± 0.45         0.76 ± 0.35              0.006                
  Value of *p*                                 0.053               0.003                                         
  Glucose \[mmol/l\]                           Female (*n* = 50)   5.60 ± 0.60              6.20 ± 1.90          0.141
  Male (*n* = 56)                              5.40 ± 0.40         5.90 ± 1.70              0.128                
  Value of *p*                                 0.178               0.548                                         
  Cholesterol \[mmol/l\]                       Female (*n* = 50)   5.10 ± 0.90              4.10 ± 0.90          0.005
  Male (*n* = 56)                              4.90 ± 0.80         4.70 ± 1.13              0.44                 
  Value of *p*                                 0.40                0.034                                         
  HDL-C \[mmol/l\]                             Female (*n* = 50)   1.39 ± 0.31              0.90 ± 0.12          0.0001
  Male (*n* = 56)                              1.29 ± 0.29         1.03 ± 0.26              0.02                 
  Value of *p*                                 0.07                0.001                                         
  LDL-C \[mmol/l\]                             Female (*n* = 50)   2.95 ± 0.33              2.02 ± 0.46          0.001
  Male (*n* = 56)                              3.03 ± 0.41         3.11 ± 0.61              0.563                
  Value of *p*                                 0.48                0.001                                         
  Triglycerides \[mmol/l\]                     Female (*n* = 50)   1.69 ± 0.54              2.02 ± 0.44          0.003
  Male (*n* = 56)                              1.78 ± 0.42         2.26 ± 0.51              0.001                
  Value of *p*                                 0.164               0.105                                         
  AIP                                          Female (*n* = 50)   0.09 ± 0.05              0.35 ± 0.13          0.001
  Male (*n* = 56)                              0.13 ± 0.09         0.34 ± 0.11              0.001                
  Value of *p*                                 0.07                0.961                                         
  TC/HDL-C                                     Female (*n* = 50)   3.67 ± 1.10              4.56 ± 1.53          0.026
  Male (*n* = 56)                              3.89 ± 1.09         4.56 ± 1.44              0.056                
  Value of *p*                                 0.523               0.967                                         
  CoQ~10~/LDL-C \[µmol/mmol\]                  Female (*n* = 50)   0.44 ± 0.14              0.19 ± 0.08          0.001
  Male (*n* = 56)                              0.46 ± 0.16         0.29 ± 0.12              0.001                
  Value of *p*                                 0.45                0.001                                         

AIP -- The atherogenic index of plasma, defined as log(TG/HDL-C),

^a^results are presented as mean ± SD,

^b^p values are calculated by unpaired t test with Welch\'s correction

Regarding plasma cholesterol; female smokers showed significantly decreased plasma concentrations of total cholesterol compared with female non-smokers (*p* \< 0.005) and male smokers (*p* \< 0.03). Regarding HDL-C, male smokers showed significantly (*p* \< 0.02) lower HDL-C than non-smoker males, whereas no significant differences were found in HDL-C concentrations between male and female non-smokers. Female smokers showed the lowest concentrations of plasma HDL-C (0.9 ± 0.12 mmol/l), which was significantly lower (*p* \< 0.001) than non-smoker females. No gender differences were found in LDL-C concentrations between non-smoker groups, however in smoker groups, females showed significantly lower LDL-C than males (*p* \< 0.001). Female smokers showed also significantly decreased LDL-C than non-smoker females (*p* \< 0.001). Men showed higher triglycerides than women both in the non-smoking group and in the smoker group, but this trend did not reach statistical significance, whereas smokers in both in male and female groups showed significantly increased triglycerides compared with their non-smoker counterparts (*p* \< 0.001 and 0.003, respectively).

[Table II](#T0002){ref-type="table"} also shows the average values of the atherogenic indices AIP, TC/HDL-C, and CoQ~10~/LDL-C. All indices showed significant differences between smokers and non-smokers irrespective of sex, but CoQ~10~/LDL-C was the only index differing significantly between female and male smokers (*p* \< 0.001).

Spearman\'s correlation analyses of data are presented in [Table III](#T0003){ref-type="table"}. Plasma CoQ~10~ concentrations were significantly correlated with TC and LDL-C only in female smokers. No correlations were observed between CoQ~10~ and age, BMI, glucose, HDL-C, or triglycerides.

###### 

The correlation between plasma coenzyme Q~10~ (CoQ~10~) and biochemical parameters in studied groups

  Parameter[a](#TF0006){ref-type="table-fn"}   Group                                     Non-smokers (*n* = 51)                      Smokers (*n* = 55)                            
  -------------------------------------------- ----------------------------------------- ------------------------------------------- --------------------------------------------- --
  Age \[years\]                                Female (*n* = 50)                         0.196                                       0.399                                         
  Male (*n* = 56)                              −0.22                                     0.106                                                                                     
  BMI \[kg/m^2^\]                              Female (*n* = 50)                         0.400                                       0.477                                         
  Male (*n* = 56)                              0.321                                     0.326                                                                                     
  Glucose \[mmol/l\]                           Female (*n* = 50)                         0.107                                       0.342                                         
  Male (*n* = 56)                              0.024                                     0.333                                                                                     
  Cholesterol \[mmol/l\]                       Female (*n* = 50)                         0.258                                       0.630[\*\*\*](#TF0009){ref-type="table-fn"}   
  Male (*n* = 56)                              0.397[\*](#TF0007){ref-type="table-fn"}   0.301                                                                                     
  HDL-C \[mmol/l\]                             Female (*n* = 50)                         −0.266                                      0.093                                         
  Male (*n* = 56)                              0.090                                     0.209                                                                                     
  LDL-C \[mmol/l\]                             Female (*n* = 50)                         0.199                                       0.577[\*\*](#TF0008){ref-type="table-fn"}     
  Male (*n* = 56)                              0.426[\*](#TF0007){ref-type="table-fn"}   0.031                                                                                     
  Triglycerides \[mmol/l\]                     Female (*n* = 50)                         0.477[\*\*](#TF0008){ref-type="table-fn"}   −0.182                                        
  Male (*n* = 56)                              −0.030                                    0.297                                                                                     
  AIP                                          Female (*n* = 50)                         0.238                                       0.334                                         
  Male (*n* = 56)                              0.182                                     0.271                                                                                     
  TC/HDL-C                                     Female (*n* = 50)                         0.158                                       0.397                                         
  Male (*n* = 56)                              0.224                                     0.309                                                                                     
  CoQ~10~/LDL-C \[µmol/mmol\]                  Female (*n* = 50)                         0.274                                       0.596[\*\*\*](#TF0009){ref-type="table-fn"}   
  Male (*n* = 56)                              0.146                                     0.466[\*\*](#TF0008){ref-type="table-fn"}                                                 

^a^Results are presented as a correlation coefficient,

^\*^significant at p \< 0.05,

^\*\*^significant at p \< 0.01,

^\*\*\*^significant at p \< 0.001

Discussion {#S0012}
==========

Cigarette smoking has a negative impact on oxidant defense systems not only through the production of reactive oxygen species (ROS) in smoke but also through the consumption of the body reserve of antioxidants \[[@CIT0031]--[@CIT0033]\]. In addition to these data, our results show that smoking has a negative impact on the plasma levels of the antioxidant CoQ~10~. These results support the assumption that smoking induced-oxidative stress may be the result of, and/or the cause of, decreased plasma CoQ~10~ \[[@CIT0033]\].

The impact of smoking on plasma CoQ~10~ was significantly more marked in female than male smokers (*p* \< 0.003). The same trend has been reported in previous studies which demonstrated that CoQ~10~ is affected by gender \[[@CIT0025], [@CIT0034]\]. This finding may provide an additional factor for the higher vulnerability to the detrimental effects of cigarette smoking in female compared with male smokers. Previous studies have emphasized that females may respond differently to tobacco-specific carcinogens based on several factors, including that females having higher DNA adduct levels, an increased CYP1A1 expression, a decreased DNA repair capacity and an increased incidence of K-ras gene mutations \[[@CIT0035]--[@CIT0038]\].

Additional factors have been suggested to contribute to interindividual susceptibility to smoking-related morbidity and mortality including BMI \[[@CIT0039]\], age \[[@CIT0040]\], and total cholesterol \[[@CIT0041]\]. Therefore, we studied these parameters in relation to plasma CoQ~10~ concentrations of healthy smokers and non-smokers. In agreement with Wolters and Hahn study \[[@CIT0042]\], no significant correlation was found between CoQ~10~ levels and BMI or age. However, results of the present study show that smoking is associated with abnormal lipid profile, and that these abnormalities were more significantly evident in female than male smokers. Female smokers exhibited significantly lower TC, LDL-C, and HDL-C values than both female non-smokers (*p* \< 0.005; *p* \< 0.024; *p* \< 0.0001 respectively), and male smokers (*p* \< 0.03; *p* \< 0.042; *p* \< 0.028 respectively). These findings are in agreement with a previous study in women aged less than 50 years \[[@CIT0043]\]. These findings are in agreement with the Munster Heart Study (PROCAM) \[[@CIT0044]\] and the Framingham Study \[[@CIT0045]\] which reported decreased TC and LDL-C concentrations in smokers but not in non-smokers. These studies have also found evidence that total mortality in middle-aged men is increased at low TC and LDL-C concentrations in smokers but not in non-smokers \[[@CIT0044], [@CIT0045]\].

The relationship between serum TC level and mortality rate was found U-shaped as a result of a U-shaped association with mortality from infectious diseases, a negative association with mortality from cancer and alcohol-related diseases, and a positive association with mortality from cardiovascular diseases and diabetes/nephropathy. Accumulated evidence suggests that a low cholesterol level may be a metabolic consequence of cancer rather than a precursor \[[@CIT0046]\]. Moreover, increasing evidence now suggests that low cholesterol levels are associated with not only cancer, but also adverse effects on the brain causing neuropsychiatric syndromes \[[@CIT0047]\] and haemorrhagic stroke \[[@CIT0048]\]. In the present study, results showed a significant positive correlation between CoQ~10~ plasma concentrations and TC and LDL-C (both at *p* \< 0.001) only in female smokers. This relationship suggests that those subjects with lower TC and LDL-C, as in the situation of female smokers, are more likely to have lower CoQ~10~, and therefore could be more prone to cancer, infectious and brain diseases later in their life.

Moreover, these data are in agreement with earlier studies demonstrating a close connection between CoQ~10~ and plasma lipids, as about 60% of plasma CoQ~10~ is associated with LDL-C, and that CoQ~10~ is mainly associated with plasma lipids rather than with cellular components \[[@CIT0049], [@CIT0050]\].

Numerous studies have indicated that LDL-C is associated with atherosclerosis plaque initiation and vulnerability to rupture, while cigarette smoking is more associated with plaque progression \[[@CIT0051]\]. The atherogenic index of plasma (AIP) that has been suggested as a marker of plasma atherogenicity \[[@CIT0028]\], was found in the present study to be significantly higher in male and female smokers (*p* \< 0.001). We further tested whether this trend is valid for other proposed atherogenic indices TC/HDL-C and TG/HDL-C \[[@CIT0052], [@CIT0053]\]. Both indices were found significantly higher in smokers than non-smokers irrespective of sex.

Studies have proposed the ratio CoQ10/LDL-C as a sensitive marker for development of atherosclerotic changes and coronary artery disease \[[@CIT0050], [@CIT0054], [@CIT0055]\]. In our study, this ratio was significantly lower in smokers compared with non-smokers; however it was significantly lower in female smokers compared with male smokers suggesting that female smokers may be at increased risk of developing atherosclerosis. In addition, this finding may provide an additional clarification for previous findings of a much stronger association between smoking and coronary heart disease in women than men \[[@CIT0051]\], which was attributable to arteriolar differences \[[@CIT0051], [@CIT0056]\].

In conclusion, this study suggests that the adverse effects of smoking are greater in females than in males, partially as a result of decreased CoQ~10~ plasma concentrations, HDL-C and total-cholesterol and abnormal atherogencity indices. There is clearly a need for further large-scale studies to be designed in such a way that they are sensitive to a range of factors that contribute to gender difference in susceptibility to smoking.
